RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy3858
         (180 letters)



>gnl|CDD|217380 pfam03133, TTL, Tubulin-tyrosine ligase family.  Tubulins and
           microtubules are subjected to several post-translational
           modifications of which the reversible
           detyrosination/tyrosination of the carboxy-terminal end
           of most alpha-tubulins has been extensively analysed.
           This modification cycle involves a specific
           carboxypeptidase and the activity of the
           tubulin-tyrosine ligase (TTL). The true physiological
           function of TTL has so far not been established.
           Tubulin-tyrosine ligase (TTL) catalyzes the
           ATP-dependent post-translational addition of a tyrosine
           to the carboxy terminal end of detyrosinated
           alpha-tubulin. In normally cycling cells, the
           tyrosinated form of tubulin predominates. However, in
           breast cancer cells, the detyrosinated form frequently
           predominates, with a correlation to tumour
           aggressiveness. On the other hand, 3-nitrotyrosine has
           been shown to be incorporated, by TTL, into the carboxy
           terminal end of detyrosinated alpha-tubulin. This
           reaction is not reversible by the carboxypeptidase
           enzyme. Cells cultured in 3-nitrotyrosine rich medium
           showed evidence of altered microtubule structure and
           function, including altered cell morphology, epithelial
           barrier dysfunction, and apoptosis. Bacterial homologs
           of TTL are predicted to form peptide tags. Some of these
           are fused to a 2-oxoglutarate Fe(II)-dependent
           dioxygenase domain.
          Length = 291

 Score = 83.9 bits (208), Expect = 6e-20
 Identities = 40/117 (34%), Positives = 66/117 (56%), Gaps = 4/117 (3%)

Query: 62  NHFPGMANLESKAILAYHLNRMKYFFPDEYNIFPKSWSLPRQWKEVISYNREHADETLIL 121
           NHFPG   +  K +L  ++ R    F  +++  P+++ LP    E + Y  ++   T I+
Sbjct: 12  NHFPGSYEITRKDLLWKNIKRQPCDFGRKFDFLPRTFILPTDLAEFVDYFEDNERNTWIV 71

Query: 122 KPTRGAEGKGIKI---LNFIPEHEVMDQDASCQVYLSNVLLINGFKFDLRVYVLMTS 175
           KP+  A G+GI+I   L+ I +  +  +    Q Y+   LLI+G KFD+R+YVL+TS
Sbjct: 72  KPSASARGRGIRITNDLSQILKQ-IQSRPLVVQKYIERPLLIDGRKFDIRLYVLVTS 127


>gnl|CDD|202916 pfam04174, CP_ATPgrasp_1, A circularly permuted ATPgrasp.  An
           ATP-grasp family that is present both as catalytically
           active and inactive versions. Contextual analysis
           suggests that it functions in a distinct peptide
           synthesis/modification system that additionally contains
           a transglutaminase, an NTN-hydrolase, the Alpha-E
           domain, and a transglutaminase fused N-terminal to a
           circularly permuted COOH-NH2 ligase. The inactive forms
           are often fused N-terminal to the Alpha-E domain.
          Length = 331

 Score = 31.5 bits (72), Expect = 0.23
 Identities = 22/74 (29%), Positives = 35/74 (47%), Gaps = 10/74 (13%)

Query: 65  PGMANLESKAILAYHLNRMKYFFPDEYNIFPK--SW--SLPRQWKEVISYNREHADETLI 120
           PG    + KA+LA+ L R+  ++  E  I P   +W    P   + V++ N +     L+
Sbjct: 238 PGTGVADDKALLAF-LPRLARYYLGEEPILPNVPTWWCGDPDDLEYVLA-NLDK----LV 291

Query: 121 LKPTRGAEGKGIKI 134
           +KP  G  G G  I
Sbjct: 292 IKPVAGYGGYGAYI 305


>gnl|CDD|183536 PRK12458, PRK12458, glutathione synthetase; Provisional.
          Length = 338

 Score = 30.8 bits (70), Expect = 0.38
 Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 21/104 (20%)

Query: 76  LAYHLNRMKYF--FPDEYNIFPKSWSLPRQWKEVISYNREHADETLILKPTRGAEGKG-I 132
           L    N++ YF  FP+E  + P +  + R  + +  +  E   + +ILKP +G+ G+G  
Sbjct: 124 LRIANNKL-YFQSFPEE--VRPTT-HISRNKEYIREFLEESPGDKMILKPLQGSGGQGVF 179

Query: 133 KI-------LNFIPEHEVMDQDASCQVYLSN-------VLLING 162
            I       LN I E    D     Q YL         +LL+NG
Sbjct: 180 LIEKSAQSNLNQILEFYSGDGYVIAQEYLPGAEEGDVRILLLNG 223


>gnl|CDD|233164 TIGR00877, purD, phosphoribosylamine--glycine ligase.  Alternate
           name: glycinamide ribonucleotide synthetase (GARS). This
           enzyme appears as a monofunctional protein in
           prokaryotes but as part of a larger, multidomain protein
           in eukaryotes [Purines, pyrimidines, nucleosides, and
           nucleotides, Purine ribonucleotide biosynthesis].
          Length = 422

 Score = 30.4 bits (69), Expect = 0.47
 Identities = 29/113 (25%), Positives = 47/113 (41%), Gaps = 20/113 (17%)

Query: 68  ANLE-SKAILAYHLNRMKYFFPDEYNIFPKSWSLPRQWKEVISYNREHADETLILKPTRG 126
           A LE SKA         K F    Y I    + +    +E  SY +E     +++K    
Sbjct: 99  AQLEGSKAF-------AKDFM-KRYGIPTAEYEVFTDPEEAKSYIQEK-GAPIVVKADGL 149

Query: 127 AEGKGIKILNFIPE-----HEVMDQ---DASCQVYLSNVLLINGFKFDLRVYV 171
           A GKG+ +     E      ++++Q   DA  +V +   L  +G +F L  +V
Sbjct: 150 AAGKGVIVAKTNEEAIKAVEDILEQKFGDAGERVVIEEFL--DGEEFSLLAFV 200


>gnl|CDD|225513 COG2965, PriB, Primosomal replication protein N [DNA replication,
           recombination, and repair].
          Length = 103

 Score = 28.6 bits (64), Expect = 0.77
 Identities = 8/34 (23%), Positives = 14/34 (41%), Gaps = 2/34 (5%)

Query: 131 GIKILNFIPEHE--VMDQDASCQVYLSNVLLING 162
           GI    F+ EH     +     QV+    + ++G
Sbjct: 25  GIPHCQFVLEHRSWQEEAGFQRQVWCEMPVRVSG 58


>gnl|CDD|148068 pfam06239, ECSIT, Evolutionarily conserved signalling intermediate
           in Toll pathway.  Activation of NF-kappaB as a
           consequence of signaling through the Toll and IL-1
           receptors is a major element of innate immune responses.
           ECSIT plays an important role in signalling to
           NF-kappaB, functioning as the intermediate in the
           signaling pathways between TRAF-6 and MEKK-1.
          Length = 229

 Score = 28.1 bits (63), Expect = 2.2
 Identities = 22/86 (25%), Positives = 34/86 (39%), Gaps = 23/86 (26%)

Query: 38  NIFPKSWSLPRQW--KEVISYNR---------EHMNHFPGMANLESKAIL---------- 76
           ++FPK   +PR     E + Y R         E M +   M + E++ +L          
Sbjct: 96  DVFPKGVFIPRNIFQAEFMHYPRQQQCAIDVLEQMENHGVMPDKETEFLLVNIFGKKSHP 155

Query: 77  AYHLNRMKYFFPDEYNIFPKSWSLPR 102
                RM Y+ P   ++ P  W LPR
Sbjct: 156 MRKYRRMMYWMPKFKHLNP--WPLPR 179



 Score = 27.0 bits (60), Expect = 5.1
 Identities = 9/24 (37%), Positives = 12/24 (50%), Gaps = 2/24 (8%)

Query: 25  HLNRMKYFFPDEYNIFPKSWSLPR 48
              RM Y+ P   ++ P  W LPR
Sbjct: 158 KYRRMMYWMPKFKHLNP--WPLPR 179


>gnl|CDD|224813 COG1901, COG1901, Uncharacterized conserved protein [Function
           unknown].
          Length = 197

 Score = 27.3 bits (61), Expect = 3.5
 Identities = 10/33 (30%), Positives = 19/33 (57%)

Query: 147 DASCQVYLSNVLLINGFKFDLRVYVLMTSKPNP 179
           D  C+   S + L +G + D+ VY+++   P+P
Sbjct: 30  DVLCRCVSSALFLSHGIRRDVVVYLVLLGPPDP 62


>gnl|CDD|176497 cd00137, PI-PLCc, Catalytic domain of prokaryotic and eukaryotic
           phosphoinositide-specific phospholipase C.  This
           subfamily corresponds to the catalytic domain present in
           prokaryotic and eukaryotic phosphoinositide-specific
           phospholipase C (PI-PLC), which is a ubiquitous enzyme
           catalyzing the cleavage of the sn3-phosphodiester bond
           in the membrane phosphoinositides (phosphatidylinositol,
           PI; Phosphatidylinositol-4-phosphate, PIP;
           phosphatidylinositol 4,5-bisphosphate, PIP2) to yield
           inositol phosphates (inositol monosphosphate, InsP;
           inositol diphosphate, InsP2;  inositol trisphosphate,
           InsP3) and diacylglycerol (DAG). The higher eukaryotic
           PI-PLCs (EC 3.1.4.11) have a multidomain organization
           that consists of a PLC catalytic core domain, and
           various regulatory domains. They play a critical role in
           most signal transduction pathways, controlling numerous
           cellular events, such as cell growth, proliferation,
           excitation and secretion. These PI-PLCs strictly require
           Ca2+ for their catalytic activity. They display a clear
           preference towards the hydrolysis of the more highly
           phosphorylated PI-analogues, PIP2 and PIP, to generate
           two important second messengers, InsP3 and DAG. InsP3
           triggers inflow of calcium from intracellular stores,
           while DAG, together with calcium, activates protein
           kinase C, which then phosphorylates other molecules,
           leading to altered cellular activity. In contrast,
           bacterial PI-PLCs contain a single catalytic domain.
           Although their precise physiological function remains
           unclear, bacterial PI-PLCs may function as virulence
           factors in some pathogenic bacteria. They participate in
           Ca2+-independent PI metabolism. They are characterized
           as phosphatidylinositol-specific phospholipase C (EC
           4.6.1.13) that selectively hydrolyze PI, not PIP or
           PIP2. The TIM-barrel type catalytic domain in bacterial
           PI-PLCs is very similar to the one in eukaryotic
           PI-PLCs, in which the catalytic domain is assembled from
           two highly conserved X- and Y-regions split by a
           divergent linker sequence. The catalytic mechanism of
           both prokaryotic and eukaryotic PI-PLCs is based on
           general base and acid catalysis utilizing two well
           conserved histidines, and consists of two steps, a
           phosphotransfer and a phosphodiesterase reaction. This
           superfamily also includes a distinctly different type of
           eukaryotic PLC, glycosylphosphatidylinositol-specific
           phospholipase C (GPI-PLC), an integral membrane protein
           characterized in the protozoan parasite Trypanosoma
           brucei. T. brucei GPI-PLC hydrolyzes the GPI-anchor on
           the variant specific glycoprotein (VSG), releasing
           dimyristyl glycerol (DMG), which may facilitate the
           evasion of the protozoan to the host#s immune system. It
           does not require Ca2+ for its activity and is more
           closely related to bacterial PI-PLCs, but not mammalian
           PI-PLCs.
          Length = 274

 Score = 26.5 bits (58), Expect = 8.0
 Identities = 13/61 (21%), Positives = 16/61 (26%), Gaps = 5/61 (8%)

Query: 91  YNIFPKSWSLPRQWKEVISY-NREHADETLILKPTRGAEGKGIKILNFIPEHEVMDQDAS 149
              +P   S    W       N           P     G GI IL+F      M Q  +
Sbjct: 214 SRNYPSGTSGGTAWYYYAMDSNNYMPQMFWNANP----AGCGIVILDFQTMDLPMQQYMA 269

Query: 150 C 150
            
Sbjct: 270 V 270


>gnl|CDD|223516 COG0439, AccC, Biotin carboxylase [Lipid metabolism].
          Length = 449

 Score = 26.5 bits (59), Expect = 8.7
 Identities = 7/31 (22%), Positives = 16/31 (51%), Gaps = 1/31 (3%)

Query: 104 WKEVISYNREHADETLILKPTRGAEGKGIKI 134
            +E ++   E     +I+K   G  G+G+++
Sbjct: 141 NEEALAIAEEIGYP-VIVKAAAGGGGRGMRV 170


>gnl|CDD|222734 pfam14397, ATPgrasp_ST, Sugar-transfer associated ATP-grasp.  A
           member of the ATP-grasp fold predicted to be involved in
           the biosynthesis of cell surface polysaccharides.
          Length = 284

 Score = 26.6 bits (59), Expect = 9.1
 Identities = 18/92 (19%), Positives = 29/92 (31%), Gaps = 11/92 (11%)

Query: 56  YNREHMNHFPGMANLESKAILAYHLNRMKYFFPDEYNIFPKSWSLPRQW---------KE 106
           Y    +       N      L    +     F +   I    +   R +          E
Sbjct: 3   YTSRELPRVSYRLNDRRYTELFEDKSIFGELFHEGLPIPQIIFQGGRDFLDLRSHADESE 62

Query: 107 VISYNREHADETLILKPTRGAEGKGIKILNFI 138
            +++ R H  + L +KP  G  GKGI+ L   
Sbjct: 63  FVAFCRNH--KPLFVKPVDGMGGKGIEKLELD 92


>gnl|CDD|223267 COG0189, RimK, Glutathione synthase/Ribosomal protein S6
           modification enzyme (glutaminyl transferase) [Coenzyme
           metabolism / Translation, ribosomal structure and
           biogenesis].
          Length = 318

 Score = 26.2 bits (58), Expect = 9.8
 Identities = 14/72 (19%), Positives = 26/72 (36%), Gaps = 8/72 (11%)

Query: 61  MNHFPGMANLESKAILAYHLNRMKYFFPDEYNIFPKSWSLPRQWKEVISYNREHADETLI 120
           +N    +    +K      L +     P            P +  E ++   EH    ++
Sbjct: 108 INDPQSIRRCRNKLYTTQLLAKAGIPVPPTLITRD-----PDEAAEFVA---EHLGFPVV 159

Query: 121 LKPTRGAEGKGI 132
           LKP  G+ G+G+
Sbjct: 160 LKPLDGSGGRGV 171


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.322    0.137    0.434 

Gapped
Lambda     K      H
   0.267   0.0696    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 9,516,169
Number of extensions: 864048
Number of successful extensions: 624
Number of sequences better than 10.0: 1
Number of HSP's gapped: 623
Number of HSP's successfully gapped: 19
Length of query: 180
Length of database: 10,937,602
Length adjustment: 91
Effective length of query: 89
Effective length of database: 6,901,388
Effective search space: 614223532
Effective search space used: 614223532
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 56 (25.4 bits)